Q4 2021 Oasmia Pharmaceutical AB Earnings Call Transcript
Ladies and gentlemen, welcome to the Oasmia Pharmaceutical Audiocast Teleconference Q4 2021. (Operator Instructions) Today, I'm pleased to present CEO, Francois Martelet; and CFO, Fredrik Jarrsten. Speakers, Please go ahead.
()-
Thank you, and good morning, everyone. So I'm Francois Martelet working as CEO and I'm joined today with -- by our CFO, Fredrik Jarrsten, and thank you very much for joining us to review our Q4 and year-end results. We indeed look forward to getting your questions at the end of this presentation.
Let's move to Slide 1, which is the forward-looking statement. But of course, we would but ask you that you read carefully, still important legal information.
So Slide 2. I mean, certainly, we did a lot over the last year in the transformation process of the company. We have listed here key steps, and that includes where the design, the articulation, the implementation of a new strategy in order to become a Nordic oncology powerhouse in the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
